menu toggle

Answering four key questions about HTA market archetypes

By AmerisourceBergen

How understanding the nuances can help biopharma companies succeed
Chelsey Campbell, Director, Global Consulting, explains why biopharma companies must understand the commonly established HTA market archetypes to better impact the commercialization process. Enter your information below to learn more.
Topics:
Commercialization Consulting Policy

Related Content

Manufacturers

Q&A – Preparing for the EU Joint Clinical Assessment (JCA) process

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
The EU JCA process

Manufacturers

Podcast: Collaborative perseverance to bring change to medicine access

Inverted color AmerisourceBergen icon
AmerisourceBergen
August 2023
insights into the workings of the JCA process

Manufacturers

First 10 drugs for Medicare price negotiation announced under IRA

Corey Ford
Corey Ford, MHA
August 2023
Washington DC Capital